Richard W. Frazee
Fondateur chez Secretory IgA, Inc.
Postes actifs de Richard W. Frazee
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Secretory IgA, Inc.
 Secretory IgA, Inc. Pharmaceuticals: MajorHealth Technology Secretory IgA, Inc. provides drug discovery and development services. It offers secretory immunoglobulin A, a biological therapeutic, which treats Clostridium difficile-associated disease. It develops orally available agents for the treatment of intestinal diseases mediated by bacterial toxins. The company founded by Michael R. Simon, Stephen C. Brown and Richard W. Frazee is headquartered in Ann Arbor, MI. | Directeur Technique/Scientifique/R&D | 20/09/2011 | - |
| Fondateur | 20/09/2011 | - |
Historique de carrière de Richard W. Frazee
Anciens postes connus de Richard W. Frazee
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| University of Michigan | Corporate Officer/Principal | - | - |
| The Johns Hopkins University | Corporate Officer/Principal | - | - |
| Rowan University | Corporate Officer/Principal | - | - |
Formation de Richard W. Frazee
| University of Minnesota | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sectorielle
| Consumer Services | 5 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Secretory IgA, Inc.
Secretory IgA, Inc. Pharmaceuticals: MajorHealth Technology Secretory IgA, Inc. provides drug discovery and development services. It offers secretory immunoglobulin A, a biological therapeutic, which treats Clostridium difficile-associated disease. It develops orally available agents for the treatment of intestinal diseases mediated by bacterial toxins. The company founded by Michael R. Simon, Stephen C. Brown and Richard W. Frazee is headquartered in Ann Arbor, MI. | Health Technology |
- Bourse
- Insiders
- Richard W. Frazee
- Expérience
